Pamela Gangar
Overview
Explore the profile of Pamela Gangar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jebiwott S, Gutapaka N, Sumari D, Loss G, Athuman T, Nyandele J, et al.
BMJ Open
. 2024 Mar;
14(3):e082227.
PMID: 38538037
Introduction: As malaria declines, low-density malaria infections (LMIs) represent an increasing proportion of infections and may have negative impacts on child health and cognition, necessitating development of targeted and effective...
2.
Litvinov I, Tetzlaff M, Thibault P, Gangar P, Moreau L, Watters A, et al.
Oncoimmunology
. 2017 Jun;
6(5):e1306618.
PMID: 28638728
Cutaneous T-Cell Lymphomas (CTCL) are rare, but potentially devastating malignancies, whose pathogenesis remains poorly elucidated. Unfortunately, currently it is not possible to predict based on the available criteria in which...
3.
Talpur R, Sui D, Gangar P, Dabaja B, Duvic M
Clin Lymphoma Myeloma Leuk
. 2015 Dec;
16(1):49-56.
PMID: 26702474
Introduction: Large cell transformation (LCT) of mycosis fungoides (MF) is associated with an aggressive clinical course, poor overall survival (OS), and variable CD30 expression. Patients And Methods: We retrospectively analyzed...
4.
Duvic M, Tetzlaff M, Gangar P, Clos A, Sui D, Talpur R
J Clin Oncol
. 2015 Aug;
33(32):3759-65.
PMID: 26261247
Purpose: Brentuximab vedotin, a monoclonal antibody (cAC10) conjugated to monomethyl auristatin E, targets CD30(+) receptors. This phase II open-label trial was conducted to evaluate safety and efficacy in CD30(+) cutaneous...
5.
Gangar P, Venkatarajan S
Dermatol Clin
. 2015 Jul;
33(3):489-96.
PMID: 26143428
Granulomatous cutaneous T-cell lymphomas (CTCL) and lymphomatoid granulomatosis are considered granulomatous lymphoproliferative disorders. The most common types of granulomatous CTCL are granulomatous mycosis fungoides and granulomatous slack skin. Lymphomatoid granulomatosis...
6.
Litvinov I, Tetzlaff M, Rahme E, Jennings M, Risser D, Gangar P, et al.
Cancer Med
. 2015 Jul;
4(9):1440-7.
PMID: 26136403
Cutaneous T-cell lymohomas (CTCLs) are rare, but potentially devastating malignancies, with Mycosis fungoides and Sézary Syndrome being the most common. In our previous study, we identified and described regions of...
7.
Litvinov I, Tetzlaff M, Rahme E, Habel Y, Risser D, Gangar P, et al.
Cancer
. 2015 Mar;
121(12):1993-2003.
PMID: 25728286
Background: Cutaneous T-cell lymphomas (CTCLs) (mycosis fungoides and its leukemic variant, Sezary syndrome) are rare malignancies. Reports of the occurrence of mycosis fungoides in married couples and families raise the...
8.
de la Garza Bravo M, Patel K, Loghavi S, Curry J, Torres Cabala C, Cason R, et al.
Hum Pathol
. 2015 Feb;
46(4):558-69.
PMID: 25666664
Lymphomatoid papulosis (LyP) lies within the spectrum of primary cutaneous CD30-positive lymphoproliferative disorders. Approximately 10% to 15% of patients with LyP develop other lymphomas, most commonly mycosis fungoides (MF), suggesting...
9.
Hoppe R, Harrison C, Tavallaee M, Bashey S, Sundram U, Li S, et al.
J Am Acad Dermatol
. 2014 Dec;
72(2):286-92.
PMID: 25476993
Background: Standard-dose (36-Gy) total skin electron beam therapy (TSEBT) is a highly effective treatment in mycosis fungoides. However, the regimen is time-intensive and may be associated with significant toxicity. Objective:...
10.
Talpur R, Thompson A, Gangar P, Duvic M
Clin Lymphoma Myeloma Leuk
. 2014 Mar;
14(4):297-304.
PMID: 24589156
Background: This study aimed to assess the long-term tolerability of pralatrexate alone or in combination with oral bexarotene for relapsed or refractory mycosis fungoides (MF). Patients And Methods: Patients with...